These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29872675)
1. The effect of melasma on self-esteem: A pilot study. Jiang J; Akinseye O; Tovar-Garza A; Pandya AG Int J Womens Dermatol; 2018 Mar; 4(1):38-42. PubMed ID: 29872675 [TBL] [Abstract][Full Text] [Related]
2. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma. Basit A; Rahman A; Uddin R J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548 [TBL] [Abstract][Full Text] [Related]
3. Oral Tranexamic Acid for the Treatment of Melasma: A Case Series and Novel Dosing Regimen. Foss M; Nethers K; Bhukhan A; Nathoo R J Drugs Dermatol; 2022 Apr; 21(4):393-398. PubMed ID: 35389597 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of oral tranexamic acid as a novel treatment for melasma with a high benefit-risk ratio. Simpson J; Peng L; Ting W J Cosmet Dermatol; 2022 Nov; 21(11):6393-6399. PubMed ID: 35972476 [TBL] [Abstract][Full Text] [Related]
5. Self-Esteem, Depression, Anxiety and Quality of Life in Patients with Melasma Living in a Sunny Mediterranean Area: Results from a Prospective Cross-Sectional Study. Platsidaki E; Efstathiou V; Markantoni V; Kouris A; Kontochristopoulos G; Nikolaidou E; Rigopoulos D; Stratigos A; Gregoriou S Dermatol Ther (Heidelb); 2023 May; 13(5):1127-1136. PubMed ID: 36995579 [TBL] [Abstract][Full Text] [Related]
6. Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial. Padhi T; Pradhan S Indian J Dermatol; 2015; 60(5):520. PubMed ID: 26538719 [TBL] [Abstract][Full Text] [Related]
7. Melasma Treatment: An Evidence-Based Review. McKesey J; Tovar-Garza A; Pandya AG Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study. Tehranchinia Z; Saghi B; Rahimi H Dermatol Res Pract; 2018; 2018():8350317. PubMed ID: 30079087 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Melasma on the Quality of Life in a Sample of Women Living in Singapore. Harumi O; Goh CL J Clin Aesthet Dermatol; 2016 Jan; 9(1):21-4. PubMed ID: 26962388 [TBL] [Abstract][Full Text] [Related]
10. Oral tranexamic acid with a triple combination cream versus oral tranexamic acid monotherapy in the treatment of severe melasma. Martinez-Rico JC; Chavez-Alvarez S; Herz-Ruelas ME; Sosa-Colunga SA; Ocampo-Candiani J; Suro-Santos Y; Vazquez Martinez O J Cosmet Dermatol; 2022 Aug; 21(8):3451-3457. PubMed ID: 35340120 [TBL] [Abstract][Full Text] [Related]
11. What should be considered in treatment of melasma. Kang HY; Ortonne JP Ann Dermatol; 2010 Nov; 22(4):373-8. PubMed ID: 21165205 [TBL] [Abstract][Full Text] [Related]
12. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300 [TBL] [Abstract][Full Text] [Related]
13. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma. Grimes PE Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882 [TBL] [Abstract][Full Text] [Related]
14. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser. Wang JV; Christman MP; Feng H; Ferzli G; Jeon H; Geronemus RG J Cosmet Dermatol; 2021 Jan; 20(1):105-109. PubMed ID: 33174686 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study. Minni K; Poojary S J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2636-2644. PubMed ID: 32567734 [TBL] [Abstract][Full Text] [Related]
16. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial. Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028 [TBL] [Abstract][Full Text] [Related]
17. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation. Hawwam SA; Ismail M; El-Attar YA Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730 [TBL] [Abstract][Full Text] [Related]
18. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma. Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318 [TBL] [Abstract][Full Text] [Related]